However, this explanation would not account for the fact that some tauopathies, particularly progressive supranuclear palsy, may demonstrate significantly decreased CSF p-tau concentrations even compared to controls [85]. The gene discussed is MAPT; the disease is Classical progressive supranuclear palsy.